Abstract
Aims
Our purpose was to determine the incidence of electrocardiographic (ECG) abnormalities in patients with organic erectile dysfunction (ED) and to compare the results with an age-matched control (potent) group.
Methods
A total of 218 men with ED of organic etiology formed our study group. A total of 210 age-matched men who had urologic disease other than ED served as control group. An experienced cardiologist who was blind to the primary diagnosis evaluated the ECGs in the entire group. The results were reported as either normal or abnormal according to the presence or absence of an abnormality suggestive for cardiovascular disease.
Results
The mean age of the study and control groups was 58 years (range for the study group 28–82 years and for the control group 28–80 years). Abnormal ECG rates among patients with ED and control subjects were comparable. The incidences of ECG abnormalities in the study and control groups were 21.1% and 17.1%, respectively (P = 0,298). No ECG abnormality was detected in males younger than 40 in either group.
Conclusion
Middle-aged or older men with ED may carry potential risk for cardiovascular diseases in the absence of cardiovascular symptoms. However, patients with organic ED are not under increased risk for ECG abnormalities.
Similar content being viewed by others
References
NIH (1993) Consensus Development panel on Impotence: NIH Consensus Conference: Impotence. JAMA 270:83–90
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994) Impotence and its medical and psychosocial correlates: results of the Massachusetts male aging study. J Urol 151:54–61
Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB, McKinlay JB (2000) Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study. Prev Med 30:328–338
Ledda A (2000) Cigarette smoking, hypertension and erectile dysfunction. Curr Med Res Opin 16(Suppl 1):13–16
Sullivan M, Keoghane S, Miller M (2001) Vascular risk factors and erectile dysfunction. BJU Int 87:838–845
Greenstein A, Chen J, Miller H, Matzkin H, Villa Y, Braf Z (1997) Does severity of ischemic coronary disease correlate with erectile function? Int J Impot Res 9:123–126
Cheitlin MD, Hutter AM, Brindis RG, Ganz P, Kaul S, Russell RO, Zumsan RM (1999) Use of sildenafil (Viagra) in patients with cardiovascular disease. Circulation 99:168–177
Solomon H, Man JW, Wierzbicki AS, Jackson G (2003) Relation of erectile dysfunction to angiographic coronary artery disease. Am J Cardiol 91:230–231
Montorsi F, Briganti A, Salonia A, Rigatti P, Margonato A, Macchi A, Galli S, Ravagnani PM, Montorsi P (2003) Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease. Eur Urol 44:360–364
Lue TF, Takamura T, Schmidt RA, Palubinskas AJ, Tanagho EA (1983) Hemodynamics of erection in the monkey. J Urol 130:1237–1241
DeBusk RF, Pepine CJ, Glasser DB, Shpilsky A, DeRiesthal H, Sweeney M (2004) Efficacy and safety of sildenafil citrate in men with erectile dysfunction and stable coronary artery disease. Am J Cardiol 93:147–153
Jackson G (2000) Sexual intercourse and stable angina pectoris. Am J Cardiol 86:35–37
De Bacquer D, De Backer G, Kornitzer M, Blackburn H (1998) Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women. Heart 80:570–577
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tokgoz, H., Yaman, O., Gulec, S. et al. Electrocardiographic abnormalities in patients with organic erectile dysfunction: comparison with an age-matched control group. Int Urol Nephrol 40, 373–376 (2008). https://doi.org/10.1007/s11255-007-9263-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-007-9263-1